Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05259436 · ClinicalTrials.gov registry record · NA

Collaborative Approach to Examining Adversity and Building Resilience Study

A NA study of Caregiver Stress and Early Life Adversity, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
300
Enrollment target
4
Study locations

NCT05259436 is a NA study of Caregiver Stress and Early Life Adversity that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 300 participants, above the 168-participant average among 5 other Caregiver Stress trials with a reported enrollment target (79% higher). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05259436, a NA study of Caregiver Stress and Early Life Adversity, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
4
Study locations

Study Summary

To examine the behavioral, psychosocial, and biologic impact of resilience-promoting interventions associated with primary care.

Interventions

  • BEHAVIORAL Caregiver-child Intervention
  • BEHAVIORAL Enhanced Primary Care

Study Locations (4)

California

  • UCSF Benioff Children's Hospital Oakland - Oakland
  • LifeLong Medical Care - Richmond
  • Zuckerberg San Francisco General Hospital and Trauma Center - San Francisco
  • Santa Barbara Neighborhood Clinics - Santa Barbara

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-04-11
Est. Completion 2025-06-30
Phase NA

What the Registry Record Tells You About NCT05259436

The ClinicalTrials.gov registry entry for NCT05259436 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 168-participant average among 5 other Caregiver Stress trials with a reported enrollment target (79% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Caregiver Stress appearing as the primary indexed condition, and to 2 interventions - of which Caregiver-child Intervention is the first listed.

NCT05259436 reports 4 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05259436 about?

NCT05259436 is a clinical study titled "Collaborative Approach to Examining Adversity and Building Resilience Study". To examine the behavioral, psychosocial, and biologic impact of resilience-promoting interventions associated with primary care.

What is the current status of trial NCT05259436?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-04-11. Estimated completion is 2025-06-30.

What conditions does trial NCT05259436 study?

This clinical trial studies the following conditions: Caregiver Stress, Early Life Adversity.

What interventions are being tested in trial NCT05259436?

The interventions under investigation include: Caregiver-child Intervention (BEHAVIORAL), Enhanced Primary Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT05259436?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05259436 being conducted?

This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caregiver Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.